Sophia R Larson1, Justin A Pieper1, Edward A Hulten2, Edward P Ficaro3, James R Corbett4,5, Venkatesh L Murthy4,5, Richard L Weinberg6. 1. Department of Medicine, University of Michigan, Ann Arbor, MI, USA. 2. Fort Belvoir Community Hospital, VA and Uniformed Services University, Bethesda, MD, USA. 3. INVIA Medical Imaging Solutions, Ann Arbor, MI, USA. 4. Division of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA. 5. Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, MI, USA. 6. Division of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA. rlweinbe@med.umich.edu.
Abstract
BACKGROUND: With appropriate protocols, F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can visualize myocardial inflammation. Optimal protocols and normative myocardial FDG uptake values are not well-established. METHODS: We evaluated 111 patients referred for inflammation cardiac FDG PET/CT. Patients followed a low-carbohydrate, high-fat diet for 36 hours before imaging and received unfractionated heparin. Glucose and fatty acid metabolism biomarkers were obtained. Mean blood pool and maximum myocardial uptake (SUVmean, SUVmax) were measured, avoiding areas of abnormal FDG uptake or spillover. RESULTS: Adequate suppression of myocardial FDG uptake occurred in 95% of patients (n = 106). Myocardial SUVmax was significantly below background blood pool SUVmean: septal myocardial to blood pool ratio 0.75 (95% CI 0.73-0.77; P < 0.001); lateral myocardial to blood pool ratio 0.70 (95% CI 0.68-0.72; P < 0.001). Glucose, insulin, and C-peptide correlated to blood pool SUVmean (Spearman rs = 0.39, P < 0.01; rs = 0.40, P < 0.01; rs = 0.35, P < 0.01) and myocardial SUVmax (Spearman rs = 0.31, P < 0.01; rs = 0.31, P < 0.01; rs = 0.26, P < 0.01). Fatty acid metabolism biomarkers did not correlate to myocardial SUVmax. CONCLUSIONS: Patients following intensive metabolic preparation have myocardial FDG SUVmax below background SUVmean. Biomarkers of glucose metabolism modestly correlate to FDG uptake.
BACKGROUND: With appropriate protocols, F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can visualize myocardial inflammation. Optimal protocols and normative myocardial FDG uptake values are not well-established. METHODS: We evaluated 111 patients referred for inflammation cardiac FDG PET/CT. Patients followed a low-carbohydrate, high-fat diet for 36 hours before imaging and received unfractionated heparin. Glucose and fatty acid metabolism biomarkers were obtained. Mean blood pool and maximum myocardial uptake (SUVmean, SUVmax) were measured, avoiding areas of abnormal FDG uptake or spillover. RESULTS: Adequate suppression of myocardial FDG uptake occurred in 95% of patients (n = 106). Myocardial SUVmax was significantly below background blood pool SUVmean: septal myocardial to blood pool ratio 0.75 (95% CI 0.73-0.77; P < 0.001); lateral myocardial to blood pool ratio 0.70 (95% CI 0.68-0.72; P < 0.001). Glucose, insulin, and C-peptide correlated to blood pool SUVmean (Spearman rs = 0.39, P < 0.01; rs = 0.40, P < 0.01; rs = 0.35, P < 0.01) and myocardial SUVmax (Spearman rs = 0.31, P < 0.01; rs = 0.31, P < 0.01; rs = 0.26, P < 0.01). Fatty acid metabolism biomarkers did not correlate to myocardial SUVmax. CONCLUSIONS:Patients following intensive metabolic preparation have myocardial FDG SUVmax below background SUVmean. Biomarkers of glucose metabolism modestly correlate to FDG uptake.
Authors: Michael T Osborne; Edward A Hulten; Venkatesh L Murthy; Hicham Skali; Viviany R Taqueti; Sharmila Dorbala; Marcelo F DiCarli; Ron Blankstein Journal: J Nucl Cardiol Date: 2016-06-08 Impact factor: 5.952
Authors: Asbjørn M Scholtens; Laurens E Swart; Henryk J Te Kolste; Ricardo P J Budde; Marnix G E H Lam; Hein J Verberne Journal: J Nucl Cardiol Date: 2017-06-05 Impact factor: 5.952
Authors: Sami El-Dalati; Venkatesh L Murthy; Anna B Owczarczyk; Christopher Fagan; James Riddell; Sandro Cinti; Richard L Weinberg Journal: J Nucl Cardiol Date: 2019-09-04 Impact factor: 5.952
Authors: B Wilk; H Smailovic; G Wisenberg; J Sykes; J Butler; M Kovacs; J D Thiessen; F S Prato Journal: J Nucl Cardiol Date: 2021-01-18 Impact factor: 3.872
Authors: Senthil Selvaraj; Kenneth B Margulies; Supritha Dugyala; Erin Schubert; Ann Tierney; Zoltan Arany; Daniel A Pryma; Svati H Shah; J Eduardo Rame; Daniel P Kelly; Paco E Bravo Journal: J Nucl Med Date: 2021-10-21 Impact factor: 11.082